Latest Press Releases

May 17, 2022

Avantor® Releases 2022 Sustainability Report, Highlighting Significant Progress in Environmental, Social and Governance (ESG) Efforts

Report outlines work done to date to advance priorities of Avantor's Science for Goodness sustainability platform RADNOR, Pa., May 17, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading...

CORPORATE

May 13, 2022

Avantor® Announces Conversion of Mandatory Convertible Preferred Stock

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced...

CORPORATE

May 12, 2022

Jonathan Peacock Elected Chairman of the Board of Directors of Avantor®

The board of directors of Avantor, Inc. (NYSE: AVTR) a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied...

May 10, 2022

Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers

Collaboration will accelerate plasmid optimization and sourcing services for new and existing viral vector and mRNA-based vaccine and therapeutic customers RADNOR, Pa., May 10, 2022 /PRNewswire/...

BIOPHARMA

May 4, 2022

Avantor® Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today...

CORPORATE

Apr 28, 2022

Avantor® Reports First Quarter 2022 Results

Net sales of $1.95 billion, increase of 9.2%; organic net sales growth of 5.1% Net income of $190.4 million; Adjusted EBITDA of $423.1 million Diluted GAAP EPS of $0.28; adjusted EPS of $0.38...

Show more press releases

Spotlight

See how Avantor sets science in
motion to create a better world.